OthersLinezolidBenzylpenicillinAmikacinCefotaximeCiprofloxacinFosfomycinTeicoplaninImipenem/cilastatinDaptomycinPiperacillinCefozopranCeftazidimeDibekacinDoripenem
Cefoperazone/sulbactamMinocyclineClindamycinIsepamicin
CefotiamVancomycin
LevofloxacinFlomoxef
AmpicillinCefepime
CefmetazoleMeropenemTazobactam/piperacillin
Ampicillin/sulbactamCefazolin
Ceftriaxone
0 0.02 0.04 0.06 0.08 0.1 0.12 0.14 0.16 0.18
Defined Daily Doses / 1,000 inhabitants /day
DID (DDDs/1,000 inhabitants/day) of injectable antibiotic use by patient type (inpatient or outpatient) in 2017
※ The DDD is according to data published in 2017.※ Drugs other than the top 30 used are classified as “others”
OthersAmikacinMetronidazolePazufloxacinLinezolidIsepamicinBenzylpenicillinCefotaximeCiprofloxacinImipenem/cilastatinTeicoplaninPiperacillinDaptomycinCefozopran
CeftazidimeDoripenem
ClindamycinMinocycline
Cefoperazone/sulbactamCefotiam
VancomycinLevofloxacin
FlomoxefAmpicillin
CefepimeCefmetazole
MeropenemTazobactam/piperacillin
Ampicillin/sulbactamCeftriaxoneCefazolin
0 0.02 0.04 0.06 0.08 0.1 0.12
Defined Daily Doses / 1,000 inhabitants /day
DID (DDDs/1,000 inhabitants/day) of injectable antibiotic use by patient type (inpatient) in 2017
※ The DDD is according to data published in 2017.※ Drugs other than the top 30 used are classified as “others”
Others
Cefepime
Ampicillin/sulbactam
Meropenem
Amikacin
Lincomycin
Cefotiam
Levofloxacin
Minocycline
Fosfomycin
Flomoxef
Clindamycin
Cefazolin
Dibekacin
Isepamicin
Ceftriaxone
0 0.01 0.02 0.03 0.04 0.05 0.06
Defined Daily Doses / 1,000 inhabitants /day
DID (DDDs/1,000 inhabitants/day) of injectable antibiotic use by patient type (outpatient) in 2017
※ The DDD is according to data published in 2017.※ Drugs other than the top 15 used are classified as “others”
OthersPazufloxacinBenzylpenicillinCefotaximeAmikacinTeicoplaninCiprofloxacinDaptomycinFosfomycinImipenem/cilastatinPiperacillinCefozopranCeftazidime
DibekacinDoripenem
Cefoperazone/sulbactamMinocyclineClindamycin
VancomycinIsepamicin
CefotiamLevofloxacin
AmpicillinFlomoxef
CefepimeCefmetazole
Tazobactam/piperacillinMeropenem
Ampicillin/sulbactamCefazolin
Ceftriaxone
0 0.02 0.04 0.06 0.08 0.1 0.12 0.14 0.16 0.18
Defined Daily Doses / 1,000 inhabitants /day
DID (DDDs/1,000 inhabitants/day) of injectable antibiotic use by patient type (inpatient or outpatient) in 2016
※ The DDD is according to data published in 2017.※ Drugs other than the top 30 used are classified as “others”
OthersMetronidazoleAmikacinLinezolidPazufloxacinIsepamicinBenzylpenicillinCefotaximeTeicoplaninCiprofloxacinDaptomycinImipenem/cilastatinPiperacillinCefozopran
CeftazidimeDoripenemClindamycin
MinocyclineCefoperazone/sulbactam
CefotiamVancomycin
LevofloxacinFlomoxef
AmpicillinCefepime
CefmetazoleTazobactam/piperacillin
MeropenemAmpicillin/sulbactam
CeftriaxoneCefazolin
0 0.02 0.04 0.06 0.08 0.1 0.12
Defined Daily Doses / 1,000 inhabitants /day
DID (DDDs/1,000 inhabitants/day) of injectable antibiotic use by patient type (inpatient) in 2016
※ The DDD is according to data published in 2017.※ Drugs other than the top 30 used are classified as “others”
Others
Ampicillin/sulbactam
Cefepime
Meropenem
Amikacin
Levofloxacin
Cefotiam
Lincomycin
Minocycline
Fosfomycin
Flomoxef
Clindamycin
Cefazolin
Dibekacin
Isepamicin
Ceftriaxone
0 0.01 0.02 0.03 0.04 0.05 0.06
Defined Daily Doses / 1,000 inhabitants /day
DID (DDDs/1,000 inhabitants/day) of injectable antibiotic use by patient type (outpatient) in 2016
※ The DDD is according to data published in 2017.※ Drugs other than the top 15 used are classified as “others”
OthersBenzylpenicillinPazufloxacinCefotaximeAmikacinDaptomycinTeicoplaninCiprofloxacinFosfomycinImipenem/cilastatinPiperacillinCeftazidimeCefozopran
DibekacinDoripenem
Cefoperazone/sulbactamMinocycline
ClindamycinVancomycinLevofloxacinIsepamicin
CefotiamAmpicillin
FlomoxefCefepimeCefmetazole
Tazobactam/piperacillinMeropenem
Ampicillin/sulbactamCefazolin
Ceftriaxone
0 0.02 0.04 0.06 0.08 0.1 0.12 0.14 0.16 0.18
Defined Daily Doses / 1,000 inhabitants /day
DID (DDDs/1,000 inhabitants/day) of injectable antibiotic use by patient type (inpatient or outpatient) in 2015
※ The DDD is according to data published in 2017.※ Drugs other than the top 30 used are classified as “others”
OthersAmikacinArbekacin
LinezolidBenzylpenicillinPazufloxacinIsepamicinCefotaximeDaptomycinTeicoplaninCiprofloxacinImipenem/cilastatinPiperacillin
CeftazidimeCefozopran
DoripenemClindamycinMinocycline
Cefoperazone/sulbactamLevofloxacin
VancomycinCefotiam
AmpicillinFlomoxef
CefepimeCefmetazole
Tazobactam/piperacillinMeropenem
Ampicillin/sulbactamCeftriaxone
Cefazolin
0 0.02 0.04 0.06 0.08 0.1 0.12
Defined Daily Doses / 1,000 inhabitants /day
DID (DDDs/1,000 inhabitants/day) of injectable antibiotic use by patient type (inpatient) in 2015
※ The DDD is according to data published in 2017.※ Drugs other than the top 30 used are classified as “others”
Others
Ampicillin/sulbactam
Cefepime
Meropenem
Levofloxacin
Amikacin
Cefotiam
Lincomycin
Minocycline
Fosfomycin
Flomoxef
Clindamycin
Cefazolin
Dibekacin
Isepamicin
Ceftriaxone
0 0.01 0.02 0.03 0.04 0.05 0.06
Defined Daily Doses / 1,000 inhabitants /day
DID (DDDs/1,000 inhabitants/day) of injectable antibiotic use by patient type (outpatient) in 2015
※ The DDD is according to data published in 2017.※ Drugs other than the top 15 used are classified as “others”
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
Def
ined
Dai
ly D
oses
/ 1,
000
inha
bita
nts
/day
Change in injectable antibiotic use by age category (2013–2017)
Over 64 years of age Between 15 and 64 years of age Under 15 years of age
